Claude Sportès

Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation

James N. Kochenderfer, Mark E. Dudley, Robert O. Carpenter et al. · Blood · 2013 · 590 citations · Full text

Medicine, Hematology, Immunology +13

Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

Claude Sportès, Frances T. Hakim, Sarfraz Memon et al. · The Journal of Experimental Medicine · 2008 · 467 citations · Full text

Life Sciences, Immunology, Clinical Immunology +16

IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory Cells

Steven A. Rosenberg, Claude Sportès, Mojgan Ahmadzadeh et al. · Journal of Immunotherapy · 2006 · 441 citations · Full text

Life Sciences, Immunology, Oncology +16

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

Jeffrey I. Cohen, Elaine S. Jaffe, Janet K. Dale et al. · Blood · 2011 · 308 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +7

Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy

Claude Sportès, Rebecca Babb, Michael Krumlauf et al. · Clinical Cancer Research · 2010 · 222 citations · Full text

Life Sciences, Immunology, Pharmacology +17